ARC
NXTM

Absolute Return Capital’s NxStage Medical Inc. NXTM Stock Holding History

Absolute Return Capital’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-15,730
Closed -$226K – 1093
2014
Q2 		$226K Buy
+15,730
New +$205K ﹤0.01% 997

Other funds holding NXTM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
BA
Broadview Advisors Milwaukee, Wisconsin $324M AUM 0.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Absolute Return Capital's NXTM Position: Q3 2014 in Review

Absolute Return Capital sold out of NxStage Medical Inc. (NXTM) in Q3 2014, closing a stake of 15,730 shares — an estimated $226K sold.

Absolute Return Capital first reported a position in NXTM in Q2 2014 and held it in 1 quarter. The position peaked at $226K in Q2 2014. 111 funds tracked by Wall St. Rank hold NXTM as of Q3 2014.

  • Absolute Return Capital reported no remaining NxStage Medical Inc. position as of Q3 2014 after selling out during the quarter.
  • Absolute Return Capital sold 15,730 NxStage Medical Inc. shares in Q3 2014, an estimated $226K.
  • Absolute Return Capital first reported a position in NxStage Medical Inc. in Q2 2014 and held it in 1 quarter.
  • Absolute Return Capital's NxStage Medical Inc. position peaked at $226K in Q2 2014.
  • 111 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2014.

Based on Absolute Return Capital's 13F filing for Q3 2014, filed 14 Nov 2014.